Prevention and Treatment of Amatoxin Induced Hepatic Failure With Intravenous Silibinin ( Legalon SIL): An Open Multicenter Clinical Trial
Phase of Trial: Phase II/III
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Silibinin (Primary)
- Indications Poisoning
- Focus Therapeutic Use
- Sponsors Madaus
- 21 Dec 2017 Status changed from active, no longer recruiting to recruiting.
- 26 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Apr 2017 Planned End Date changed from 1 Dec 2016 to 31 Dec 2018.